| [1] |
Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2007[J]. CA Cancer J Clin, 2007, 57(1):43-66.
|
| [2] |
Bonnet D, Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J]. Nat Med,1997, 3(7):730-7.
|
| [3] |
Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859):105-11.
|
| [4] |
Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells[J]. Nat Rev Cancer,2006, 6(6):425-36.
|
| [5] |
Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells[J]. Cancer Res, 2007, 67(3):1030-7.
|
| [6] |
Olempska M, Eisenach PA, Ammerpohl O, et al.Detection of tumor stem cell markers in pancreatic carcinoma cell lines[J]. Hepatobiliary Pancreat Dis Int, 2007, 6(1):92-7.
|
| [7] |
Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer[J]. Cell Stem Cell, 2007, 1(3):313-23.
|
| [8] |
Jimeno A, Feldmann G, Suárez-Gauthier A, et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development[J]. Mol Cancer Ther,2009, 8(2):310-4.
|
| [9] |
Li C, Wu JJ, Hynes M, et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target[J]. Gastroenterology, 2011, 141(6):2218-27.
|
| [10] |
Matsuda Y, Naito Z, Kawahara K, et al.Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis[J]. Cancer Biol Ther, 2011, 11(5):512-23.
|
| [11] |
Zhou J, Wang CY, Liu T，et al. Persistence of side population cells with high drug efflux capacity in pancreatic cancer[J]. World J Gastroenterol,2008,14(6):925-30.
|
| [12] |
Yao J, Cai HH, Wei JS, et al. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells[J]. Oncol Rep,2010, 23(5):1375-82.
|
| [13] |
Wang YH, Li F, Luo B, et al. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics[J]. Neoplasma,2009, 56(5):371-8.
|
| [14] |
Zhang SN, Huang FT, Huang YJ, et al. Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells[J].Tumori,2010, 96(6):985-92.
|
| [15] |
Dembinski JL, Krauss S.Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma[J].Clin Exp Metastasis,2009, 26(7):611-23.
|
| [16] |
Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis[J]. Nature, 2003, 425(6960):851-6.
|
| [17] |
Feldmann G, Dhara S, Fendrich V,et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers[J]. Cancer Res, 2007, 67(5):2187-96.
|
| [18] |
Huang FT, Zhuan-Sun YX, Zhuang YY, et al. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance[J]. Int J Oncol,2012, 41(5):1707-14.
|
| [19] |
Tang SN, Fu J, Nall D, et al. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics[J]. Int J Cancer, 2012, 131(1):30-40.
|
| [20] |
Mueller MT, Hermann PC, Witthauer J, et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer[J]. Gastroenterology,2009, 137(3):1102-13.
|
| [21] |
Lee CJ,Dosch J,Simeone DM. Pancreatic cancer stem cells[J]. J Clin Oncol,2008, 26(17):2806-12.
|
| [22] |
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008, 133(4):704-15.
|
| [23] |
Kabashima A, Higuchi H, Takaishi H, et al. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion[J]. Int J Cancer, 2009, 124(12):2771-9.
|
| [24] |
Quint K, Tonigold M, Di Fazio P, et al. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition[J]. Int J Oncol, 2012, 41(6):2093-102.
|
| [25] |
Salnikov AV, Liu L, Platen M, et al. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential[J]. PLoS One, 2012, 7(9):e46391.
|
| [26] |
Zhang Y, Wei J, Wang H, et al. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer[J].Oncol Rep,2012, 27(5):1599-605.
|
| [27] |
Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression[J]. Clin Cancer Res,2000, 6(9):3530-5.
|
| [28] |
Singh S, Srivastava SK, Bhardwaj A, et al. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy[J]. Br J Cancer, 2010, 103(11):1671-9.
|
| [29] |
Shah AN,Summy JM,Zhang J,et al.Development and characterization of gemcitabine-resistant pancreatic tumor cells[J]. Ann Surg Oncol, 2007, 14(12):3629-37.
|
| [30] |
Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells[J]. Nat Med, 2006, 12(10):1167-74.
|
下载:
